Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations

Volume: 2018, Pages: 1 - 8
Published: Jan 1, 2018
Abstract
Primary liver cancer is a common kind of digestive cancers with high malignancy, causing 745,500 deaths each year. Hepatocellular carcinoma is the major pathological type of primary liver cancer. Traditional treatment methods for patients with hepatocellular carcinoma have shown poor efficacy in killing residual cancer cells for a long time. In recent years, tumor immunotherapy has emerged as a promising method owing to its safety and efficacy...
Paper Details
Title
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
Published Date
Jan 1, 2018
Volume
2018
Pages
1 - 8
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.